Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aiyingda
- Development stage
- Preclinical
- Lead developer
- 罗益
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
**Aiyingda** is a pediatric combined vaccine developed by Luoyi Wuxi Biopharmaceutical for prevention of invasive disease caused by *Neisseria meningitidis* serogroups A and C and *Haemophilus influenzae* type b. It contains meningococcal capsular polysaccharide antigens from serogroups A and C together with a Hib conjugate antigen. The product is intended to induce antigen-specific protective immune responses, including antibodies against the relevant bacterial capsular polysaccharides. A randomized open-label study in healthy children aged 12–23 months evaluated one-dose and two-dose schedules for immunogenicity, immune persistence, and safety.
- Brand names
- Aiyingda
- Other names
- AC-Hib combined vaccineGroup A and C meningococcal polysaccharide and Haemophilus influenzae type b conjugate vaccine
02
Targets
Neisseria meningitidis group C capsular polysaccharideNmA CPS (Neisseria meningitidis group A capsular polysaccharide)
Beyond the preview
Go deeper on Aiyingda.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Aiyingda.